RankingsPricing
  1. US-listed companies
  2. OCULAR THERAPEUTIX, INC
  3. Financials
  4. Working capital

OCULAR THERAPEUTIX, INCOCUL

Market cap
$2.3B
P/E ratio
SummaryFinancials
Period EndWorking capital (Million USD)YoY (%)
Dec 31, 202431+29.70%
Dec 31, 202324+32.56%
Dec 31, 202218+2.15%
Dec 31, 202118+65.61%
Dec 31, 202011+4491.45%
Dec 31, 20190-109.19%
Dec 31, 2018-3-20.97%
Dec 31, 2017-3+83.86%
Dec 31, 2016-2+7.55%
Dec 31, 2015-2+90.87%
Dec 31, 2014-1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)